| DB ID | MyCo_1139 |
| Title | Prognostic significance of serum β-d-glucan levels in 78 patients with Trichosporon fungemia |
| Year | 2012 |
| PMID | 22832213 |
| Fungal Diseases involved | Trichosporon fungemia |
| Associated Medical Condition | Hematological disorders |
| Genus | Trichosporon |
| Species | spp. |
| Organism | Trichosporon spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Prognostic |
| Biomolecule | Protein |
| Geographical Location | Canada |
| Cohort | The clinical data from a total 84 patients with Trichosporon fungemia were collected from 43 hospitals. Among the 78 patients (60 males and 18 females, median age 56 (range 16–78) years) who were evaluated for their serum b-D-glucan levels, 70 had underlying hematological malignancies or other hematological disorders associated with a poor prognosis. |
| Cohort No. | 78 |
| Age Group | 16–78 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | BDG assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | BDG Assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
